A $13.5 Billion Global Opportunity for Glutamic Acid by 2026 - New Research from StrategyR

News provided by

Feb 18, 2022, 10:00 ET

SAN FRANCISCO, Feb. 18, 2022 /PRNewswire/ -- A new market study published by Global Industry Analysts Inc., (GIA) the premier market research company, today released its report titled "Glutamic Acid - Global Market Trajectory & Analytics". The report presents fresh perspectives on opportunities and challenges in a significantly transformed post COVID-19 marketplace.

FACTS AT A GLANCE
What's New for 2022?

Global competitiveness and key competitor percentage market shares
Market presence across multiple geographies - Strong/Active/Niche/Trivial
Online interactive peer-to-peer collaborative bespoke updates
Access to our digital archives and MarketGlass Research Platform
Complimentary updates for one year

Edition: 9; Released: February 2022
Executive Pool: 883
Companies: 53 - Players covered include Ajinomoto Co., Inc.; Akzo Nobel N.V.; Bachem AG; Evonik Industries AG; Iris Biotech GmbH; Kyowa Hakko Bio Co., Ltd.; Luojiang Chenming Biological Products Co.; Ningxia EPPEN Biotech Co.,ltd.; Sichuan Tongsheng Amino Acid Co., Ltd.; Suzhou Yuanfang Chemical Co. Ltd.; and Others.
Coverage: All major geographies and key segments
Segments: Application (Food & Beverage, Animal Feed, Pharmaceutical, Other Applications)
Geographies: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Complimentary Project Preview - This is an ongoing global program. Preview our research program before you make a purchase decision. We are offering a complimentary access to qualified executives driving strategy, business development, sales & marketing, and product management roles at featured companies. Previews provide deep insider access to business trends; competitive brands; domain expert profiles; and market data templates and much more. You may also build your own bespoke report using our MarketGlass™ Platform which offers thousands of data bytes without an obligation to purchase our report. Preview Registry

ABSTRACT-

Global Glutamic Acid Market to Reach US$13.5 Billion by the Year 2026

Glutamic acid, also known as glutamate, is a non-essential amino acid that is critical for effective functioning of cells. The amino acid is also essential for disposing off excess nitrogen from the human body. In the nervous systems, glutamic acid is a major excitatory neurotransmitter. The amino acid plays a crucial role in synaptic plasticity, and takes part in various cognitive functions in the brain including memory and learning. Glutamic acid functions as a precursor for synthesizing inhibitory GABA. Over stimulation of glutamic acid is linked to diseases such as Alzheimer's, amyotrophic lateral sclerosis and lathyrism. Glutamine is also known to promote muscle glycogen synthesis, and is hence being researched for possible improvement of muscle strength. Researchers have theorized that overtraining can lead to reduced plasma glutamine levels in athletes, which can in turn cause impairment to immune system's functions and expose athletes to various illnesses. Few studies have found less incidence of infections among athletes consuming glutamine-supplemented drink post intense training. Other studies have found that despite glutamine supplementation helping maintenance of plasma glutamine levels subsequent to intense exercise, the supplementation had limited impact on different immune response testes. Glutamine has potential to stimulate muscle glycogen synthesis.

Glutamate supplements are most often available in powder form. Glutamic acid HCL powder contains HCL (hydrochloric acid) too as it eases digestion and is easily dissolvable in liquids. While glutamic acid is safe for all adults and children, nursing or pregnant women and those suffering from epilepsy or liver or kidney disease are at risk as glutamic acid can worsen their condition.

Athletes and bodybuilders take glutamic acid supplements. This is because of the fact that glutamic acid is known to alter its structure to form glutamine that enhances muscle strength. Athletes and bodybuilders use glutamine to build muscle mass, strength, and endurance. Glutamine is also prescribed for those suffering from Colitis and Crohn's disease. It is often prescribed for those suffering from short bowel syndrome that affects patients who have had a significant portion of their small intestine removed by surgery. The FDA approves the use of glutamine for those suffering from sickle cell disease. However, using a single amino acid supplement for glutamic acid can result in a negative nitrogen balance and can adversely affect the metabolism. It can lead to growth issues in children and pregnant and breastfeeding women should steer clear of glutamic acid supplements. Some of the side effects associated with glutamic acid supplements include fatigue, headaches, or even systemic acidosis in persons whose kidneys are unable to excrete the acid from the body. Abnormal levels of glutamic acid concentrations result in overexcitation of the receiving nerve cell. Prolonged excitation can result in nerve cell toxicity and even result in a stroke or epilepsy. Calcium might flood the neurons and lead to glutamate toxicity. The prolonged calcium in the cell can lead to severe cell damage or even cell death.

Excessive glutamic acid can cause neuronal damage that leads to premature death of cells. However, the presence of glutamate transporters in glial and neuronal membranes facilitates the disposal of excessive glutamate. Glutamic acid is found in several food ingredients, and also is involved in providing the humans with the sense of taste, particularly in combination with salt. As a result, monosodium glutamate (MSG), the sodium salt of glutamic acid, is extensively used for improving the flavor and functions as a food additive. Glutamic acid is a vital energy source that is found abundantly in wheat and soybean. Amid the COVID-19 crisis, the global market for Glutamic Acid estimated at US$10 Billion in the year 2022, is projected to reach a revised size of US$13.5 Billion by 2026, growing at a CAGR of 7.1% over the analysis period. Food & Beverage, one of the segments analyzed in the report, is projected to grow at a 7.3% CAGR to reach US$11.2 Billion by the end of the analysis period. After a thorough analysis of the business implications of the pandemic and its induced economic crisis, growth in the Animal Feed segment is readjusted to a revised 6.3% CAGR for the next 7-year period. This segment currently accounts for a 12% share of the global Glutamic Acid market.

With its multiple advantages, the glutamic acid market continues to witness healthy growth. Growing demand for animal feed, food enhancers and food additives in the food & beverage industry are some of the main reasons for the increasing demand for this product. With increasing awareness about consumption of healthy products, glutamic acid demand in the pharmaceutical, beverage and food industry has increased. Processed food and animal feed industries especially stands out and will witness significant growth due to increasing global population, growing meat and dairy products consumption, rise in disposable income, and increasing demand for healthier, more nutritional, tastier, and higher quality meat food products. This trend would in turn fuel the glutamic acid market growth. Ready-to-eat foods and processed foods are expected to boost glutamic acid market growth through the forecast period, because glutamic acid is used for flavor enhancement in ready-to-eat and processed foods, as well as in food additives. Additionally, increasing numbers of health-conscious consumers are preferring natural food additives to synthetic food additives. In order to cope with the changes in the food patterns of today's consumers, manufacturers are looking at various ways to provide innovative food products. These shifting consumer trends are expected to boost the growth of glutamic acid market.

Sugarcane molasses, glucose and Coryneform bacteria are the raw materials for producing glutamic acid. Some of the main suppliers of raw materials are United States Biological, Mahajan Molasses Company, Eurosweet GmbH, Cargill, Incorporated, Roquette Frères and Ambuja Group having a strong distribution network. The various processes involved in the production of this acid are and ion exchange, crystallization, evaporation, carbon adsorption, centrifugation and fermentation. Manufacturers prefer fermenting as it gives high purity and high-quality products. Nevertheless, the manufacturing process requires high energy and it is water and capital-intensive. However, there are certain issues that are impeding market growth. The excessive intake of glutamic acid can lead to fatigue problems and headaches that may hamper market growth. Some other side effects can be swelling of face, nose and throat, skin burning sensation, rash or itchiness, weight loss or gain, breathing difficulty, dizziness, muscle pain, allergic reactions, bleeding, slow wound healing, cramps, skin thinning, nausea, mood changes, chest pain, stomach pain, bloating, cloudy urine, vomiting, abdominal pain, memory problems, depression, irritability and confusion.

The U.S. Market is Estimated at $1.5 Billion in 2022, While China is Forecast to Reach $5 Billion by 2026

The Glutamic Acid market in the U.S. is estimated at US$1.5 Billion in the year 2022. The country currently accounts for a 15.39% share in the global market. China, the world second largest economy, is forecast to reach an estimated market size of US$5 Billion by the year 2026 trailing a CAGR of 8.3% through the analysis period. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 5.2% and 6.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.9% CAGR while Rest of European market (as defined in the study) will reach US$5.5 Billion by the close of the analysis period.

Asia-Pacific region is forecast to register significant growth and become the fastest growing glutamic acid market over the upcoming years due to growing demand for food additives and processed food in countries such as Japan, India, and China. Demand for food additives is driven by increasing population and rising purchasing power of the people in these countries. These trends are expected to create huge opportunities for existing players as well as new entrants. Widespread use of monosodium glutamate (MSG) has been the key contributor to the overall amino acids market in Asia, although saturating market conditions present a challenge. China and India in particular hold promise due to their huge population, burgeoning economies, increasing income levels, and rising living standards, and the subsequent growth in demand for a range of foods & beverages. The abundant livestock population also contributes to the rising demand for glutamic acid in these regions. Some of the factors for this market growth are expansion of end-use industries such as beverage, food, ready-to-eat foods, personal care, pharmaceuticals and animal feed along with improved purchasing power of consumers and increasing awareness and adoption of healthy lifestyles. It is expected that there will be significant growth in the animal feed industry due to increasing meat and dairy product consumption, growing disposable incomes, increasing population and increasing demand for superior meat quality and processed food. As people prefer natural food additives to synthetic ones for health reasons, it is expected to have a positive impact on glutamic acid industry.

North America is a major consumer of glutamic acid, and the trend is attributed to the region's ever-growing processed food industry, especially in the US and Mexico. In Europe, increasing health concerns and new government regulations related to feed additives and public health are expected to positively impact the region's glutamic acid market. While the established market strengthened by the processed food industry's sustained growth would make North America the market leader, Europe is also expected to play a crucial role in the global glutamic acid market due to stringent government regulations that support the use of natural food additives. Growth of glutamic acid markets in North America and Europe are driven by heightened consumption of packaged and processed foods in these regions.

Pharmaceutical Segment to Reach $1.1 Billion by 2026

Glutamic acid is used in the pharmaceutical industry to stimulate nerves in neural drugs, in the treatment of bipolar disorder, schizophrenia and muscular dystrophy, hypoglycemic coma, epilepsy, ulcers, mental retardation, nerve damage during chemotherapy, neurotransmission imbalances, behavioral and cognitive problems among individuals and for metabolic disorders. Glutamates are salts of glutamic acid and are non-essential amino acids. They are metabolized in the brain and act as neurotransmitters in the nervous system for normal and healthy functioning of the brain. Another important function of glutamates is the disposal of excess nitrogen from the body. The sodium salt of this acid is known as monosodium glutamate (MSG) and is one of the most popular food additives. It is used as a food enhancer in cheese, bread, ice cream, carbohydrate-based snacks, processed meat, soups, salad dressings and canned vegetables. MSG is known to improve the functioning of the heart and decrease coronary disease-related chest pain.

In the global Pharmaceutical segment, USA, Canada, Japan, China and Europe will drive the 8% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$508.6 Million will reach a projected size of US$873 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$169.7 Million by the year 2026, while Latin America will expand at a 8.1% CAGR through the analysis period. More

MarketGlass™ Platform
Our MarketGlass™ Platform is a free full-stack knowledge center that is custom configurable to today`s busy business executive`s intelligence needs! This influencer driven interactive research platform is at the core of our primary research engagements and draws from unique perspectives of participating executives worldwide. Features include - enterprise-wide peer-to-peer collaborations; research program previews relevant to your company; 3.4 million domain expert profiles; competitive company profiles; interactive research modules; bespoke report generation; monitor market trends; competitive brands; create & publish blogs & podcasts using our primary and secondary content; track domain events worldwide; and much more. Client companies will have complete insider access to the project data stacks. Currently in use by 67,000+ domain experts worldwide.

Our platform is free for qualified executives and is accessible from our website www.StrategyR.com or via our just released mobile application on iOS or Android

About Global Industry Analysts, Inc. & StrategyR™
Global Industry Analysts, Inc., (www.strategyr.com) is a renowned market research publisher the world`s only influencer driven market research company. Proudly serving more than 42,000 clients from 36 countries, GIA is recognized for accurate forecasting of markets and industries for over 33 years.

CONTACTS:
Zak Ali
Director, Corporate Communications
Global Industry Analysts, Inc.
Phone: 1-408-528-9966
www.StrategyR.com
Email: [email protected]

LINKS
Join Our Expert Panel
https://www.strategyr.com/Panelist.asp

Connect With Us on LinkedIn
https://www.linkedin.com/company/global-industry-analysts-inc./

Follow Us on Twitter
https://twitter.com/marketbytes

Journalists & Media
[email protected]

SOURCE Global Industry Analysts, Inc.